Skip to main content
logo
Divi's Laboratories Limited (NSE:DIVISLAB)
India flag India · Delayed Price · Currency is INR
6,473.50
-45.00 (-0.69%)
Nov 18, 2025, 3:29 PM IST

Divi's Laboratories Revenue

Divi's Laboratories had revenue of 27.15B INR in the quarter ending September 30, 2025, with 16.12% growth. This brings the company's revenue in the last twelve months to 100.29B, up 16.43% year-over-year. In the fiscal year ending March 31, 2025, Divi's Laboratories had annual revenue of 93.60B with 19.31% growth.

Revenue (ttm)
100.29B
Revenue Growth
+16.43%
P/S Ratio
17.14
Revenue / Employee
9.51M
Employees
10,542
Market Cap
1.72T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202593.60B15.15B19.31%
Mar 31, 202478.45B780.00M1.00%
Mar 31, 202377.67B-11.93B-13.31%
Mar 31, 202289.60B19.90B28.56%
Mar 31, 202169.69B15.75B29.20%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries549.64B
Aurobindo Pharma325.14B
Cipla279.66B
Zydus Lifesciences244.94B
Apollo Hospitals Enterprise232.65B
Biocon164.76B
Glenmark Pharmaceuticals161.53B
Alkem Laboratories138.90B
Revenue Rankings

Divi's Laboratories News

More News